Back to search
FDAFDA · Food and drugs·Recall number D-1577-2019

Papaverine/Phentolamine/Alprostadil/Atropine 30 mg/2 mg/50 mcg/0.15 mg/mL Injectable, 2.5 mL Vial, Rx only, Compounded by Wise Pharmacy, Littleton, CO 80123.

Published August 7, 2019 · Recall initiated: July 22, 2019

Summary

FDA records drug Class II recall D-1577-2019, published August 7, 2019 and initiated July 22, 2019. Recalling firm: Wise Pharmacy; Status: Terminated; Reported quantity: 14 vials; Lot: Lot #: 6153N, Exp8/29/2019. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Processing Controls

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Wise Pharmacy
Distributor
CO, TX, WY
Lot
Lot #: 6153N, Exp8/29/2019
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Papaverine/Phentolamine/Alprostadil/Atropine 30 mg/2 mg/50 mcg/0.15 mg/mL Injectable, 2.5 mL Vial, Rx only, Compounded by Wise Pharmacy, Littleton, CO 80123. recalled?

Yes. FDA published recall D-1577-2019 on August 7, 2019. Reported hazard: Lack of Processing Controls

What should I do if I have this product?

Voluntary: Firm initiated · Letter